Kikuo Arakawa

Kikuo Arakawa's AcademicInfluence.com Rankings

Kikuo Arakawa

Philosophy

#8376

World Rank

#11740

Historical Rank

Logic

#5408

World Rank

#6803

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Kikuo Arakawa's Degrees

Doctorate Medicine Kyoto University

Why Is Kikuo Arakawa Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Kikuo Arakawa's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial (2006) (850)
Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation. (2003) (471)
Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. (2000) (361)
1993 Guidelines for the Management of Mild Hypertension: Memorandum From a World Health Organization/ International Society of Hypertension Meeting (1993) (348)
Blood pressure and hormonal responses to aerobic exercise. (1985) (231)
Increased chymase-dependent angiotensin II formation in human atherosclerotic aorta. (1999) (206)
Antihypertensive and volume-depleting effects of mild exercise on essential hypertension. (1987) (203)
The Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension (2009) (199)
Electrophysiological Properties in Chronic Lone Atrial Fibrillation (1991) (167)
The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. (1993) (165)
Antihypertensive mechanism of exercise. (1993) (160)
1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. (1993) (152)
Differences in tissue angiotensin II-forming pathways by species and organs in vitro. (1998) (144)
Comparison of nifedipine retard with angiotensin converting enzyme inhibitors in Japanese hypertensive patients with coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) randomized trial. (2004) (140)
Relation between green tea consumption and the severity of coronary atherosclerosis among Japanese men and women. (2000) (140)
Role of locally formed angiotensin II and bradykinin in the reduction of myocardial infarct size in dogs. (1993) (137)
Plasma fibrinogen levels as an independent indicator of severity of coronary atherosclerosis. (1989) (131)
Effect of acute exercise on plasma immunoreactive-atrial natriuretic factor. (1986) (115)
A long-term aerobic exercise program decreases the obesity index and increases the high density lipoprotein cholesterol concentration in obese children. (1987) (102)
Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding (1997) (98)
Chronic variant of myocarditis associated with hepatitis C virus infection. (1997) (95)
Summary of 1993 World Health Organisation-International Society of Hypertension guidelines for the management of mild hypertension. Subcommittee of WHO/ISH Mild Hypertension Liaison committee. (1993) (95)
Blood pressure lowering effect of low intensity aerobic training in elderly hypertensive patients. (1998) (88)
A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy. (1999) (84)
The effects of long-term low intensity aerobic training and detraining on serum lipid and lipoprotein concentrations in elderly men and women (2004) (81)
Serum glycoproteins and severity of coronary atherosclerosis. (1995) (80)
The relationship of structure to pressor and oxytocic actions of isoleucine5 angiotensin octapeptide and various analogues (1961) (79)
Cholesterol Paradox in Patients with Paroxysmal Atrial Fibrillation (2000) (77)
INFLUENCE OF WORKLOAD ON THE ANTIHYPERTENSIVE EFFECT OF EXERCISE (1992) (73)
Chymase inhibition suppresses high-cholesterol diet-induced lipid accumulation in the hamster aorta. (2002) (72)
Low energy synchronous transcatheter cardioversion of atrial flutter/fibrillation in the dog. (1990) (68)
In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques. (2000) (67)
Angiotensin II formation by an alternative pathway during exercise in humans (1994) (67)
Band neutrophil count and the presence and severity of coronary atherosclerosis. (1996) (66)
Effects of gamma-oryzanol on serum lipids and apolipoproteins in dyslipidemic schizophrenics receiving major tranquilizers. (1990) (66)
Genetic analysis of the epithelial sodium channel in Liddle's syndrome (1998) (63)
Taurine amplifies renal kallikrein and prevents salt‐induced hypertension in Dahl rats (1994) (62)
Pravastatin use and risk of coronary events and cerebral infarction in Japanese men with hypercholesterolemia: The Kyushu Lipid Intervention Study (KLIS) (2000) (61)
A proposed conformation of isoleucyl5-angiotensin II (1962) (61)
Quantity and function of high density lipoprotein as an indicator of coronary atherosclerosis. (1999) (58)
The Use of p-Nitrobenzyl Esters in Peptide Synthesis1 (1959) (57)
Serine protease angiotensin II systems. (1996) (56)
Apolipoprotein(a) phenotypes and serum lipoprotein(a) levels in maintenance hemodialysis patients with/without diabetes mellitus. (1993) (56)
Alcohol consumption, serum lipids and severity of angiographically determined coronary artery disease. (1990) (55)
What types of hypertensives respond better to mild exercise therapy? (1988) (55)
Changes in serum concentrations of taurine and other amino acids in clinical antihypertensive exercise therapy. (1989) (55)
Ability of kallikrein to generate angiotensin II-like pressor substance and a proposed ‘kinin–tensin enzyme system’ (1980) (55)
Role of Prehypertension in the Development of Coronary Atherosclerosis in Japan (2004) (52)
Compound heterozygosity for an apolipoprotein A1 gene promoter mutation and a structural nonsense mutation with apolipoprotein A1 deficiency. (1999) (50)
[Angiotensin converting enzyme inhibitor]. (1991) (50)
Takayasu's disease: association with HLA-B5. (1978) (49)
CROSSOVER COMPARISON BETWEEN THE DEPRESSOR EFFECTS OF LOW AND HIGH WORK‐RATE EXERCISE IN MILD HYPERTENSION (1993) (48)
Increased chymase activity in internal thoracic artery of patients with hypercholesterolemia. (2000) (47)
Direct formation of angiotensin II without renin or converting enzyme in the ischemic dog heart. (1989) (46)
Nifedipine retard was as effective as angiotensin converting enzyme inhibitors in preventing cardiac events in high-risk hypertensive patients with diabetes and coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) subgroup analysis. (2004) (46)
Mild exercise decreases plasma endogenous digitalislike substance in hypertensive individuals. (1992) (46)
Angiotensin II receptor blocker-based therapy in Japanese elderly, high-risk, hypertensive patients. (2012) (46)
Salt-induced hemodynamic regulation mediated by nitric oxide (2011) (45)
An angiotensin II receptor blocker–calcium channel blocker combination prevents cardiovascular events in elderly high-risk hypertensive patients with chronic kidney disease better than high-dose angiotensin II receptor blockade alone (2012) (44)
A novel homozygous missense mutation in the apo A-I gene with apo A-I deficiency. (1998) (43)
High Cardiac Angiotensin-II-Forming Activity in Infarcted and Non-Infarcted Human Myocardium (2001) (43)
Possible induction of renal dysfunction in patients with lecithin:cholesterol acyltransferase deficiency by oxidized phosphatidylcholine in glomeruli. (1999) (42)
Relationship of cigarette smoking to blood pressure and serum lipids. (1990) (42)
Confirmation of direct angiotensin formation by kallikrein. (1983) (41)
Antihypertensive Efficacy of Olmesartan Medoxomil and Candesartan Cilexetil in Achieving 24-Hour Blood Pressure Reductions and Ambulatory Blood Pressure Goals (2011) (41)
Noradrenaline-secreting glomus jugulare tumor with cyclic change of blood pressure. (1975) (41)
Chymase Inhibitor Improves Survival in Hamsters with Myocardial Infarction (2003) (41)
Hypertension and exercise. (1993) (41)
A cysteine-containing truncated apo A-I variant associated with HDL deficiency. (1996) (41)
Troglitazone lowers blood pressure and enhances insulin sensitivity in Watanabe heritable hyperlipidemic rabbits. (1997) (41)
Mild Exercise Therapy Increases Serum High Density Lipoprotein2 Cholesterol Levels in Patients with Essential Hypertension (1989) (39)
Relationship of cigarette smoking to the severity of coronary and thoracic aortic atherosclerosis. (1995) (39)
Imidapril hydrochloride in essential hypertension: a double-blind comparative study using enalapril maleate as a control (1995) (39)
A new case of apoA-I deficiency showing codon 8 nonsense mutation of the apoA-I gene without evidence of coronary heart disease. (1995) (39)
Isolation and amino acid composition of human angiotensin I. (1967) (39)
Isolation and characterization of human apolipoprotein A-I Fukuoka (110 Glu----Lys). A novel apolipoprotein variant. (1990) (36)
Antibacterial activity of epigallocatechin gallate against methicillin-resistant Staphylococcus aureus. (1994) (35)
Improvement of accessory symptoms of hypertension by TSUMURA Orengedokuto Extract, a four herbal drugs containing Kampo-Medicine Granules for ethical use: a double-blind, placebo-controlled study. (2006) (35)
Analysis of HLA class II genes in Japanese patients with idiopathic membranous glomerulonephritis. (1992) (33)
Mechanism of the cardioprotective effect of inhibition of the renin-angiotensin system on ischemia/reperfusion-induced myocardial injury. (2001) (32)
Urinary kallikrein activity is increased during the first few weeks of exercise training in essential hypertension (1994) (32)
Decreased concentration of high density lipoprotein cholesterol in schizophrenic patients treated with phenothiazines. (1984) (32)
Serum lipoprotein (a) levels in maintenance hemodialysis patients. (1993) (32)
Seasonal variation of serum high density lipoprotein cholesterol levels in men. (1983) (32)
Kinetics of HDL-apo A-I in the WHHL rabbit, an animal model of familial hypercholesterolemia. (1989) (32)
Effects of captopril on opioid peptides during exercise and quality of life in normal subjects. (1991) (32)
Acute Pulmonary Thromboembolism Treated Successfully by Balloon Angioplasty—A Case Report (1988) (32)
Apolipoprotein E1 Lys-146----Glu with type III hyperlipoproteinemia. (1992) (32)
Difference in the incidence of cough induced by angiotensin converting enzyme inhibitors: a comparative study using imidapril hydrochloride and enalapril maleate. (1999) (31)
Lipoprotein and apolipoprotein losses during continuous ambulatory peritoneal dialysis. (1989) (31)
Different coagulability and fibrinolytic activity during exercise depending on exercise intensities. (1992) (31)
Levels of soluble cell adhesion molecules in patients with angiographically defined coronary atherosclerosis. (1999) (30)
Reperfusion-Induced Arrhythmias Are Suppressed by Inhibition of the Angiotensin II Type 1 Receptor (2003) (29)
Mild exercise activates renal dopamine system in mild hypertensives (1998) (29)
Association of class II antigens of HLA with primary glomerulopathies. (1987) (29)
Obesity, body fat distribution and coronary atherosclerosis among Japanese men and women (2001) (29)
A novel mutant, ApoA-I nichinan (Glu235-->0), is associated with low HDL cholesterol levels and decreased cholesterol efflux from cells. (1999) (28)
Role of left ventricular regional nonuniformity in hypertensive diastolic dysfunction. (1993) (27)
A single amino acid deletion in the carboxy terminal of apolipoprotein A-I impairs lipid binding and cellular interaction. (2000) (27)
Synthesis of Succinyl1-isoleucyl5-angiotensin II and N-(Poly-O-acetyl-seryl)-isoleucyl5-angiotensin II (1962) (26)
Acute myocardial infarction due to thrombus formation in congenital coronary artery fistula. (1994) (26)
An Improved Synthesis of Isoleucine5 Angiotensin Octapeptide1 (1961) (26)
Echocardiographic and electrocardiographic measures in obese children after an exercise program. (1987) (26)
Lipids and apolipoproteins in patients treated with major tranquilizers (1985) (25)
Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel bloc (2009) (25)
Beneficial effects of a serine protease inhibitor in peripheral vascular disease. (1993) (24)
Exercise, a measure to lower blood pressure and reduce other risks. (1999) (24)
A pressor formation by trypsin from renin-denatured human plasma protein. (1976) (24)
Open clinical studies on a new angiotensin II receptor antagonist, TCV 116. (1994) (24)
Chemical identity of tryptensin with angiotensin. (1980) (24)
Relationship of alcohol consumption and smoking to plasma cortisol and blood pressure. (1994) (22)
Characterization of a new human apolipoprotein A-I Yame by direct sequencing of polymerase chain reaction-amplified DNA. (1991) (22)
Identification of [hydroxyproline3]-lysyl-bradykinin released from human plasma protein by kallikrein. (1988) (22)
Reduction in serum total cholesterol and risks of coronary events and cerebral infarction in Japanese men: the Kyushu Lipid Intervention Study. (2003) (22)
Comparative pharmacodynamics of olmesartan and azelnidipine in patients with hypertension: a population pharmacokinetic/pharmacodynamic analysis. (2009) (22)
Job strain, Type A behavior pattern, and the prevalence of coronary atherosclerosis in Japanese working men. (2000) (22)
Physical exercise in the management of hypertension (2000) (22)
Proline-rich protein is a glycoprotein and an acute phase reactant. (1988) (21)
Formation of angiotensin II by tonin-inhibitor complex. (1988) (21)
Hyperinsulinemic hypoalphalipoproteinemia as a new indicator for coronary heart disease. (1999) (21)
Insulin resistance and angiographical characteristics of coronary atherosclerosis. (1999) (21)
Changes of dopamine and atrial natriuretic factor by mild exercise for hypertensives. (1991) (21)
Transesophageal low-energy synchronous cardioversion of atrial flutter/fibrillation in the dog. (1992) (20)
Putative mechanisms of action of probucol on high-density lipoprotein apolipoprotein A-I and its isoproteins kinetics in rabbits. (1990) (20)
Effects of niceritrol on levels of serum lipids, lipoprotein(a), and fibrinogen in patients with primary hypercholesterolemia. (1992) (20)
Insulin resistance observed in WHHL rabbits. (1991) (20)
Adenosine activates aromatic L-amino acid decarboxylase activity in the kidney and increases dopamine. (2001) (20)
Association between coronary heart disease and the apolipoprotein A-I/C-III/A-IV complex in a Japanese population (2004) (20)
Association of DQB1*0302 alloantigens in Japanese pediatric patients with steroid-sensitive nephrotic syndrome. (1995) (19)
An isolated left ventricular lesion associated with left ventricular tachycardia--arrhythmogenic "left" ventricular dysplasia? (1994) (19)
Kininogenase activity of tonin. (1984) (19)
Clinical effects of rosuvastatin, a new HMG-CoA reductase inhibitor, in Japanese patients with primary hypercholesterolemia: an early phase II study. (2002) (19)
Enzymatic degradation and electrophoresis of human angiotensin I. (1968) (19)
Amlodipine lowers blood pressure without increasing sympathetic activity or activating the renin-angiotensin system in patients with essential hypertension (1997) (19)
Relation of serum total cholesterol and other risk factors to risk of coronary events in middle-aged and elderly Japanese men with hypercholesterolemia: the Kyushu Lipid Intervention Study. (2004) (18)
Effect of mild aerobic exercise on serum lipids and apolipoproteins in patients with coronary artery disease. (1987) (18)
Methicillin-resistant Staphylococcus aureus (MRSA) isolated at Fukuoka University Hospital and hospitals and clinics in the Fukuoka city area. (2000) (18)
The regression of left ventricular hypertrophy by imidapril and the reduction of serum procollagen type III amino-terminal peptide in hypertensive patients. (2000) (18)
Effect of mild aerobic exercise on lipid and apolipoprotein levels in patients with essential hypertension. (1988) (18)
Effect of exercise on hypertension and associated complications. (1996) (18)
In vivo kinetics of lipoprotein(a) in homozygous Watanabe heritable hyperlipidaemic rabbits (1993) (18)
Effect of nifedipine on serum lipids, lipoproteins, and apolipoproteins in patients with essential hypertension (1987) (17)
Polymorphism of the apolipoprotein A‐IV gene and its significance in lipid metabolism and coronary heart disease in a Japanese population (1996) (17)
IX - 1993 Guidelines for management of mild hypertension. Memorandum from a WHO/ISH meeting (1993) (17)
“Torsades de pointes” and atrioventricular block (1988) (17)
Japanese Graves' disease: association with HLA-Bw46. (1987) (17)
Relation of serum total cholesterol and other factors to risk of cerebral infarction in Japanese men with hypercholesterolemia. (2004) (17)
Human chymase expression in a mice induces mild hypertension with left ventricular hypertrophy. (2003) (17)
In vivo conversion of recombinant human proapolipoprotein AI (rh-Met-proapo AI) to apolipoprotein AI in rabbits. (1993) (17)
Clinical evaluation of delapril in Japan. Report from the Japan Study Group on Delapril. (1991) (17)
Purification of Human Angiotensin (1967) (17)
Effect of simvastatin on receptor mediated metabolism of low density lipoprotein in guinea pigs. (1991) (16)
Characterization of a novel variant of apolipoprotein E, E2 Fukuoka (Arg-224 --> Gln) in a hyperlipidemic patient with xanthomatosis. (1996) (16)
Plasma HDL levels are regulated by the catabolic rate of large particles of lipoprotein containing apo-A-I. (1994) (16)
Evidence that C4b-binding protein (proline-rich protein) is synthesized by hepatocytes. (1991) (15)
Quantitative characterization of insulin-glucose response in Watanabe heritable hyperlipidemic and cholesterol-fed rabbits and the effect of cilazapril. (1994) (15)
Differential Inhibition of Bradykinin Hydrolysis by Four ACE Inhibitors: a Possible Explanation for Differences in Induced Coughing (1994) (15)
Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia. (1989) (15)
Methicillin-resistant Staphylococcus aureus (MRSA) isolated in clinics and hospitals in the Fukuoka city area. (1995) (15)
Identification of two apolipoprotein variants, A‐I Karatsu (Tyr 100 → His) and A‐I Kurume (His 162 → Gin) (1996) (15)
Prevention of hypertension and associated cardiovascular disease: a 1991 statement. Conclusions from a joint WHO/ISH meeting. (1992) (14)
Purification and characterization of a kinin‐ and angiotensin II‐forming enzyme in the dog heart (1997) (14)
Analysis of a new polymorphism in the human apolipoprotein A-I gene: association with serum lipoprotein levels and coronary heart disease. (1996) (14)
Angiotensin I converting enzyme gene polymorphism and insulin resistance in patients with angina pectoris. (1999) (14)
The best criterion for discrimination between patients with and without paroxysmal atrial fibrillation on signal-averaged electrocardiogram. (1995) (14)
Effects of polydextrose on serum lipids, lipoproteins, and apolipoproteins in healthy subjects. (1991) (14)
The Effect of Low Dose Carvedilol on Circadian Variation of Blood Pressure in Patients with Essential Hypertension (1987) (14)
Comparative effects of an angiotensin-converting enzyme inhibitor and an angiotensin II antagonist in Dahl rats. (1994) (13)
Evaluation of the Coagulation and Fibrinolytic Systems in Men with Intermittent Claudication (1996) (13)
Plasma renin activity as a more specific diagnostic aid for renal infarction. (1970) (13)
Elevated levels of HDL2-cholesterol and apo A-I in national class Japanese male marathon runners. (1988) (13)
Associations among serum lipoprotein(a) levels, apolipoprotein(a) phenotypes, and myocardial infarction in patients with extremely low and high levels of serum lipoprotein(a). (1999) (13)
Antioxidative Effects of Fluvastatin on Superoxide Anion Activated by Angiotensin II in Human Aortic Smooth Muscle Cells (2002) (13)
1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension endorsed by the Lebanese Hypertension League (1999) (13)
Family studies of the LDL receptor gene of relatively severe hereditary hypercholesterolemia associated with Achilles tendon xanthomas (1991) (13)
Nephrotic syndrome associated with hyper-high-density lipoproteinemia potentiated by prednisolone therapy. (1985) (13)
High-renin malignant hypertension secondary to an aldosterone-producing adenoma. (1990) (12)
Long-term effect of CS-514 (HMG-CoA reductase inhibitor) on serum lipids, lipoproteins, and apolipoproteins in patinets with hypercholesterolemia (1987) (12)
Combined therapy with arbekacin and fosfomycin for methicillin-resistant Staphylococcus aureus infections. (1994) (12)
Angiotensin-converting activity of tissue kallikrein. (1990) (12)
Species Specificity in Reaction between Renin and Angiotensinogen (1965) (12)
Polymorphic site study at codon 347 of apolipoprotein A-IV in a Japanese population. (1993) (12)
HLA and rheumatic heart disease in Japanese. (1983) (11)
Effects of manidipine and delapril on serum lipids, lipoproteins, and apolipoproteins in patients with mild to moderate essential hypertension: a randomized trial with one-year follow-up. (1992) (11)
Clinical Efficacy of Carvedilol in Severe Hypertension (1991) (11)
Angiotensin II forming activity of vascular endothelial and smooth muscle cells. (1993) (11)
Prognostic significance of daily physical activity after first acute myocardial infarction. (1990) (11)
Mechanism of action of probucol on cholesteryl ester transfer protein (CETP) mRNA in a Chinese hamster ovary cell line that had been stably transfected with a human CETP gene. (1998) (11)
Human urinary kallikrein can generate angiotensin II from homologous renin substrates. (1995) (11)
Substrate-dependent angiotensin II formation in the peripheral circulation. (1990) (11)
Effect of captopril on serum lipids, lipoproteins and apolipoproteins in patients with mild essential hypertension (1986) (11)
Wavelength index: a predictor of the response to disopyramide in paroxysmal lone atrial fibrillation. (1994) (11)
Acute Myocardial Infarction in a Patient with Primary Coronary Dissection and Severe Coronary Vasospasm (1995) (11)
Direct angiotensin II formation by rat submandibular gland kallikrein. (1987) (11)
Divided renal and peripheral venous renin as a means of predicting operative curability of renal hypertension. (1973) (11)
Effect of soybean crude fiber on the concentrations of serum lipids and apolipoproteins in hyperlipemic subjects. (1985) (10)
Low serum apolipoprotein A-I level in patients with vasospastic angina. (1993) (10)
In vivo kinetics of oxidatively modified HDL. (1993) (10)
A new pharmacologic phonocardiography by the use of angiotensin. (1971) (10)
Evaluation of abnormal signal-averaged electrocardiograms in young athletes. (1995) (10)
A case of a clinically "silent" pheochromocytoma. (1990) (10)
Alcohol consumption and severity of angiographically determined coronary artery disease in Japanese men and women. (2001) (9)
Quantification of the effects of troglitazone on insulin sensitivity and beta-cell function in Watanabe heritable hyperlipidemic rabbits: a minimal model analysis. (1997) (9)
Medication for hypercholesterolemia and the risk of nonfatal acute myocardial infarction: case-control study in Japan. (2002) (9)
Effects of slow-release bezafibrate on serum lipids, lipoproteins, apolipoproteins, and postheparin lipolytic activities in patients with type IV and type V hypertriglyceridemia. (1989) (9)
Mechanism of Antiarrhythmic Effects of Class Ic Drugs in Paroxysmal Atrial Fibrillation in Man (1998) (9)
Structure of a kallikrein-like enzyme and its tissue localization in the dog. (1999) (8)
A case of hyperreninemic hypertension with unilateral hydronephrosis. (1985) (8)
Comparative effects of monatepil, a novel calcium antagonist with alpha 1-adrenergic-blocking activity, and nitrendipine on lipoprotein and carbohydrate metabolism in patients with hypertension. (1994) (8)
A fast fourier transform analysis of coronary reperfusion‐induced ventricular fibrillation and the modification by dibutyryl cyclic amp in a cat model (1992) (8)
Sex differences in response to angiotensin II receptor blocker-based therapy in elderly, high-risk, hypertensive Japanese patients: a subanalysis of the OSCAR study (2014) (8)
Effects of lisinopril and bisoprolol on lipoprotein metabolism in patients with mild-to-moderate essential hypertension. (1995) (8)
The strong association of HLA-DR4 with spherical mesangial dense deposits in IgA nephropathy. (1985) (8)
Purification of tonin by chromatography using soybean trypsin inhibitor coupled CH-sepharose 4B. (1981) (8)
Reduced coronary vasodilation in patients with familial hypercholesterolemia following intracoronary injection of isosorbide dinitrate. (1995) (8)
A multicenter comparison of nicorandil and diltiazem on serum lipid, apolipoprotein, and lipoprotein levels in patients with ischemic heart disease (1992) (8)
Studies on Human Angiotensin (1967) (8)
Activation of renal dopamine system by physical exercise. (1995) (8)
Identification of [hydroxyproline3]-bradykinin released from human plasma and plasma protein Cohn's fraction IV-4 by trypsin. (1988) (8)
Angiotensin II-Forming Systems in Cardiovascular Diseases (1998) (8)
Right atrial vegetation in left ventricular‐right atrial communication (1987) (8)
ON THE OXIDATION OF NON-HYDROXYAMINO ACIDS BY PERIODIC ACID (1957) (8)
Relation between type a behavior pattern and the extent of coronary atherosclerosis in Japanese women (2002) (8)
Relation of C4b-binding protein to athero-sclerosis of the descending thoracic aorta. (1996) (8)
Two kinins formed by trypsin from human plasma protein. (1982) (8)
Effects of Chinese herbal drugs on serum lipids, lipoproteins and apolipoproteins in mild to moderate essential hypertensive patients. (1992) (7)
Plasma renin activity could be a useful predictor of left ventricular hypertrophy in essential hypertensives (1998) (7)
Short-term effects of a high-sucrose diet on plasma lipid, lipoprotein cholesterol, tissue lipoprotein lipase and hepatic triglyceride lipase in rats. (1996) (7)
Identification of two apolipoprotein variants, A-I Kaho (Asp 51-->Val) and A-I Lys 107 deletion. (1996) (7)
Apolipoprotein AI mRNA levels in WHHL rabbits. (1990) (7)
[Renin-angiotensin system in essential hypertension]. (1979) (7)
A case of hyperreninemic hypertension after extracorporeal shock-wave lithotripsy. (2000) (7)
[Pathogenesis of hypertension; a review]. (1989) (7)
Serum lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in the families of NIDDM patients (1995) (7)
Effect of captopril on high-density lipoprotein subfractions in patients with mild to moderate essential hypertension. (1989) (7)
Thrombomodulin levels in patients with coronary artery disease. (1997) (7)
A long-term comparative trial of cerivastatin sodium, a new HMG-CoA reductase inhibitor, in patients with primary hypercholesterolemia. (1998) (7)
Clinical efficacy and tolerability of candesartan cilexetil (1999) (7)
Cardiac function of WHHL rabbit, an animal model of familial hypercholesterolemia. (1990) (6)
Potent inhibition of angiotensin-converting enzyme by [des-Pro3]-bradykinin or "converstatin" in comparison with Captopril. (1985) (6)
Characterization of two new human apolipoprotein A-I variants: apolipoprotein A-I Tsushima (Trp-108-->Arg) and A-I Hita (Ala-95-->Asp). (1994) (6)
Delayed renin release in renal infarction. (1972) (6)
Nonpharmacological treatment of hypertension. (1988) (6)
Differential effectiveness of ARB plus CCB therapy and high-dose ARB therapy in high-risk elderly hypertensive patients: Subanalysis of the OSCAR study (2014) (6)
Effects of enalapril on serum lipoproteins in mild essential hypertension. (1989) (6)
Human renin activation by protease from the renin granule fraction of the dog kidney cortex. (1991) (6)
Detection of a point mutation in cholesteryl ester transfer protein gene by polymerase chain reaction-mediated site-directed mutagenesis. (1993) (6)
[Methicillin-resistant Staphylococcus aureus (MRSA) isolated in hospitals in Fukuoka City area]. (1992) (6)
Effects of fluvastatin, a new inhibitor of HMG-CoA reductase, and niceritrol on serum lipids, lipoproteins and cholesterol ester transfer activity in primary hypercholesterolemic patients. (1995) (6)
Synthesis of natural human angiotensin I. (1968) (6)
Cardioprotection of ACE inhibitor in ischemic heart is not dependent on the local angiotensin II formation. (1992) (6)
Roles of renal dopamine and kallikrein-kinin systems in antihypertensive mechanisms of exercise in rats. (2000) (6)
Pravastatin-induced changes in receptor-mediated metabolism of low density lipoprotein in guinea pigs. (1994) (5)
Synthesis of human angiotensin I. (1967) (5)
Efficient nuclear delivery of antisense oligodeoxynucleotides and selective inhibition of CETP expression by apo E peptide in a human CETP-stably transfected CHO cell line. (1999) (5)
Efficacy and safety of a new HMG-CoA reductase inhibitor, NK-104, in patients with hypertriglyceridemia — Randomized double-blind, cross-over placebo controlled study (2000) (5)
A comparative study of biapenem and imipenem/cilastatin for bacterial pneumonia (1995) (5)
In vitro conversion of recombinant human proapolipoprotein A-I to apolipoprotein A-I. (1994) (5)
Postmortem evaluation of morphologic changes in the infarcted myocardium that predict ventricular septal rupture in acute anteroseptal infarction. (1999) (5)
Plasma free and sulfoconjugated dopamine before and after a half-marathon. (1995) (5)
Effect of nifedipine, dilazep, dinitrates and propranolol on blood lactate accumulation during intensive graded exercise testing in healthy young subjects. (1988) (5)
Change in plasma renin substrate level after the intravenous furosemide administration. (1979) (4)
A comparative study of biapenem and imipenem/cilastatin for chronic respiratory tract infection. (1995) (4)
Molecular cloning of a novel rat salt-tolerant protein by functional complementation in yeast. (1996) (4)
Effects of probucol on low-density lipoprotein catabolism in guinea pigs. (1992) (4)
[Antihypertensive exercise therapy]. (1985) (4)
A proposed conformation of isoleucyl-5-angiotensin II. (1962) (4)
Effects of a Slow-Release Nifedipine on 24-Hour Ambulatory Blood Pressure and Ischemic Changes on 24-Hour Ambulatory Electrocardiogram in Patients with Severe Coronary Artery Disease (2000) (4)
Two novel frameshift mutations associated with the presence of direct repeats of the LDL receptor gene in familial hypercholesterolemia (1993) (4)
In vitro activities of arbekacin, alone and in combination, against methicillin-resistant Staphylococcus aureus. (1994) (4)
Angiotensin‐Converting Enzyme Inhibitors in Congestive Heart Failure (1987) (4)
Long-term administration of probucol and QTc interval prolongation. (1993) (4)
A missense mutation (Thr-6Pro) in the lysosomal acid lipase (LAL) gene is present with a high frequency in three different ethnic populations: Impact on serum lipoprotein concentrations (1996) (4)
Electrophysiological properties in paroxysmal atrial fibrillation complicated with the Wolff-Parkinson-White syndrome: comparison with paroxysmal atrial fibrillation alone. (1994) (3)
3-Acetoxy-1-acetyl-5-methylpyrazole, a novel acetylating reagent of protein. (1972) (3)
Reduced left ventricular diastolic asynchrony after captopril in single vessel coronary artery disease. (1992) (3)
Beneficial and adverse effects of angiotensin converting enzyme inhibitors. (1989) (3)
Proarrhythmic effects of class Ic drugs. (1993) (3)
Right bundle branch block in a patient with acute posterior myocardial infarction (1997) (3)
Apolipoproteins in human biopsied nephrotic kidneys (2006) (3)
Antibacterial activity of epigallocatechin gallate againstHelicobacter pylori: Synergistic effect with plaunotol (1997) (3)
ON THE OXIDATION OF DIPEPTIDES CONTAINING HYDROXY-AMINO ACID RESIDUE BY PERIODIC ACID (1957) (3)
Effects of a new calcium channel blocker, MPC-1304, on blood pressure, serum lipoproteins and serum carbohydrate metabolism in patients with essential hypertension. (1995) (3)
Mechanism of Action of Gemfibrozil on HDL Metabolism and Atherosclerosis in WHHL Rabbits (1997) (3)
Comparative effects of bunazosin and propranolol on serum lipids and apolipoproteins in patients with essential hypertension. (1989) (3)
Combined effects of probucol and benzafibrate on lipoprotein metabolism and liver cholesteryl ester transfer protein mRNA in cholesterol-fed rabbits. (1999) (3)
Long-term effect of low-density lipoprotein apheresis in a patient with heterozygous familial hypercholesterolemia: follow-up study using coronary angiography. (1998) (3)
Function and expression of a novel rat salt-tolerant protein: evidence of a role in cellular sodium metabolism. (1998) (3)
Takayasu's Disease : Its Clinical Studies in 26 Patients and Experimental Studies in Animals. (1970) (3)
HLA and Cardiovascular Disease : Additional Comments : SYMPOSIUM ON GENE-ENVIRONMENT INTERACTION IN CARDIOVASCULAR DISEASES (1978) (3)
Non-pharmacologic measures for lowering blood pressure (1989) (3)
Formation of vasoactive substances by trypsin--effect of pH differences on the generation. (1977) (3)
Coronary collateral circulation and diastolic function. (1994) (3)
Case report of IgA nephropathy associated with ankylosing spondylitis and HLA-B27. (1987) (3)
Combined apical hypertrophic cardiomyopathy and acute myocardial infarction with coronary stenosis. (1988) (3)
Dose-Effect Relationship of Carvedilol in Essential Hypertension (2012) (3)
Pathological substratum for clinical features of fatal myocarditis. (1987) (3)
Effects of Mild Exercise Therapy on Serum Lipids and Apoproteins (1985) (3)
Lipoprotein and Apolipoprotein Losses during Continuous Ambulatory Peritoneal Dialysis: ―腹膜透析排液中のリポ蛋白, アポ蛋白について― (1987) (3)
A new stereostethoscope devised for both monaural and binaural auscultation. (1970) (3)
Gemfibrozil suppresses atherosclerosis by preventing foam cell infiltration (1994) (3)
What is the most important in treating hypertension (2004) (2)
Kinetics and gene expression of HDL-APO A-I in the WHHL rabbit, an animal model of familial hypercholesterolemia (1994) (2)
Medium-term effects of betaxolol monotherapy and combination therapy with nitrendipine on lipoprotein and apolipoprotein metabolism in patients with mild to moderate essential hypertension. (1996) (2)
Tissue specific regulation of angiotensin II (AII) forming enzymes in 2-kidney 1-clip (2K1C) hypertensive hamster (1998) (2)
Nafamostat mesylate therapy for systemic lupus erythematosus with nephrotic syndrome: a case report (1996) (2)
Effect of bevantolol and propranolol on serum lipids in patients with essential hypertension. (1994) (2)
Urapidil in patients with severe hypertension and in long‐term treatment (1988) (2)
Inhibitory effects of kinins on angiotensin I conversion in the local circulation. (1990) (2)
Diastolic filling abnormality modified by left ventricular asynchrony in essential hypertension. (1991) (2)
Bunazosin enhances receptor-mediated endocytosis of low-density lipoproteins. (1992) (2)
Active and inactive renin after exercise (2004) (2)
Combined therapy with probucol and pravastatin in hypercholesterolaemia (1993) (2)
Alterations in lipoprotein with discontinuation of probucol (1987) (2)
Parasympathetic Tone Affects Electrocardiographic Preconditioning during Right Coronary Angioplasty (1998) (2)
The hypocholesterolemic effect of once-daily administration of probucol (1987) (2)
Mutational analysis of two frequently observed lipoprotein lipase gene variants in the Japanese population (1997) (2)
Combined effects of pravastatin and probucol on high-density lipoprotein apolipoprotein A-I kinetics in cholesterol-fed rabbits. (1995) (2)
Prevention of hypertension and associated cardiovascular disease. A 1995 statement. Conclusions from a joint WHO/ISH Meeting. (1996) (2)
Mild physical exercise may activate the adenosine-dopamine system: A new natriuretic mechanism (2002) (2)
[Relation between candidiasis and nutrition of patients and MRSA infection]. (1997) (2)
Effects of pinacidil on serum lipid, lipoprotein, and apolipoprotein levels in patients with mild to moderate hypertension. (1990) (2)
Effects of pindolol on serum lipids, apolipoproteins, and lipoproteins in patients with mild to moderate essential hypertension. (1989) (2)
Effects of oral administration of bopindolol on circadian variations in blood pressure in patients with essential hypertension (1988) (1)
Electrocardiographic Changes Related to Parasympathetic Tone during Right Coronary Angioplasty (1997) (1)
High-density lipoprotein and apolipoprotein A-I deficiency induced by combination therapy with probucol and bezafibrate (2004) (1)
A Study of Lipid Metabolism in Human Nephrotic Syndrome: II. The Significance of Urinary Lipoproteins and Presence of Apolipoproteins in Kidney Tissue@@@2. 尿中および血中リポ蛋白, アポ蛋白の相関について (1982) (1)
Effects of dibutyryl cyclic AMP on ventricular vulnerability during atrioventricular block in dog (1991) (1)
-190- EFFECTIVENESS OF A TRANSARTERIAL CATHETER TECHNIQUE FOR ELECTRICAL ABLATION OF ATRIOVENTRICULAR JUNCTION IN DOGS (1986) (1)
Effect on the combination of BIBR277 (Telmisartan), the long-acting angiotensin II AT1 receptor antagonist, with calucium antagonists or diuretics in patients with mild-to-moderate essential hypertension (2002) (1)
PJ-120 Nifedipine Retard and ACE Inhibitors Did Not Show the Similar Relationship between Cardiac Events and Achieved Systolic Blood Pressure(Hypertension, Clinical 2 (H) : PJ20)(Poster Session (Japanese)) (2004) (1)
Combination of Chymase and ACE Inhibitors Further Improves Survival in Hamsters with Myocardial Infarction (2003) (1)
Effect of a new calcium channel blocker, NZ-105, in patients with severe hypertension (1992) (1)
The long-term safety of BIBR277 (Telmisartan), the long-acting angiotensin II AT1 receptor antagonist, in patients with mild-to-moderate essential hypertension (2002) (1)
Long-term Effects of Nifedipine Retard vs ACE Inhibitors in Hypertension with Coronary Artery Disease : Final Reports of J-MIC(B) (2002) (1)
Right bundle block in a patient with acute posterior myocardial infarction. (1997) (1)
Abdominal aortic aneurysm of unknown origin and renovascular hypertension in a 25 year old male. (1989) (1)
-0276-LOW-ENERGY SYNCHRONOUS TRANSCATHETER CARDIOVERSION OF ATRIAL FLUTTER/FIBRILLATION IN DOG (1990) (1)
[Chronic perianal pyoderma with urethrocutaneous fistula: a case report]. (1998) (1)
Effect of bunitrolol administration on serum lipids, lipoproteins, and apolipoproteins in patients with essential hypertension (1986) (1)
Study of Subfractionation of HDL on 10% Agarose Gel and Its Application for the Evaluation of the Effect of Pantethine on HDL Subfractions (1982) (1)
-189-EVALUATION OF SUBSIDIARY PACEMAKER FUNCTION AFTER THE TRANSARTERIAL CATHETER ABLATION OF ATRIOVENTRICULAR JUNCTION BY OVERDRIVE SUPPRESSION AND HOLTER ECG (1986) (1)
Effects of the angiotensin converting enzyme inhibitors captopril, rentiapril, and alacepril in patients with essential and renovascular hypertension. (1989) (1)
Clinical efficacy and safety of lisinopril (MK-521) in the treatment of hypertension in patients with renoparenchymal disease or impaired renal function (1990) (1)
Plasmin and thrombin inhibitors in essentially untreated patients with coronary artery spasm. (1993) (1)
Familial hypobetalipoproteinemia associated with hypothyroidism. (1995) (1)
THE BENEFICIAL EFFECT OF EXERCISE THERAPY FOR ESSENTIAL HYPERTENSION AND A PROBABLE MECHANISM A PRELIMINARY REPORT (1984) (1)
[Tangier disease]. (1994) (1)
[Candesartan, angiotensin II receptor antagonist]. (2000) (1)
Severity of Coronary Atherosclerosis in Relation to Hypertension and Dyslipidemia (1995) (1)
Effects of arotinolol on exercise capacity and humoral factors during exercise in normal subjects (1992) (1)
Isolation of [hydroxyproline3]Lysyl-bradykinin formed by kallikrein from human plasma protein. (1989) (1)
Clinical evaluation of bevantolol hydrochloride in patients with severe hypertension. The Cooperative Study Group on Bevantolol in Japan. (1995) (1)
Efficacy and Tolerance of Carvedilol in Combination with a Thiazide Diuretic in the Treatment of Essential Hypertension (1988) (1)
[Comparison of clinical usefulness of beta-blocker in aged and younger essential hypertension. Double blind trial using bunitrolol]. (1984) (1)
[Clinical effects of labetalol on pheochromocytoma]. (1983) (1)
Effects of Chinese herbal drug, dai-saiko-to on plasma lipids, lipoproteins and liver lipid contents in guinea pig. (1991) (1)
A Case with Glycogen Storage Disease Associated with Hepatic Tumor and Severe Hypertriglyceridemia (1987) (0)
[A comparative long-term trial of sodium cerivastatin, a new HMG-CoA reductase inhibitor, in patients presenting with primary hypercholesterolemia]. (1999) (0)
[Etiological studies of hypertension. A Renin-angiotension-aldosterone system]. (1984) (0)
Effect of Chlorpromazine on High Density Lipoprotein Subfraction in Chronic Schizophrenics (1984) (0)
Evaluation of junctional rhythm during radiofrequency catheter ablation of the slow pathway in atrioventricular nodal tachycardia (1995) (0)
Effect of Prednisolone on Lipids, Lipoproteins and Apolipoproteins in Patients with Nephrotic Syndrome: ―ステロイド投与時の血中脂質の変化― (1986) (0)
Isolation and Synthesis of Human Angiotensin : Part II (1968) (0)
ARB as an Upstream Therapy for Preventing Atrial Fibrillation(Atrial Fibrillation : Innovation of the Therapeutic Strategies, The 69th Annual Scientific Meeting of the Japanese Circulation Society) (2005) (0)
CARDIAC ARRHYTHMIAS INDUCED BY TETANUS TOXIN (1975) (0)
CAN ANTIHYPERTENSIVE DRUGS IMPROVE LEFT VENTRICULAR HYPERTROPHY? : PROGRESS IN ANTI-HYPERTENSIVE VASODILATIVE THERAPY (1989) (0)
4.P.103 Angiotens in converting enzyme gene polymorphism and insulin resistance in patients with coronary heart disease (1997) (0)
Chymase-dependent angiotensin II formation causes mild hypertension and cardiac hypertrophy (2002) (0)
Evaluation of coronary atherosclerosis by transesophageal echocardiography (1994) (0)
2.P.80 Effects of cerivastatin 0.3 mg daily compared to 0.15 mg in patients with hypercholesterolemia (1997) (0)
Effects of fluvastatin on angiotensin II induced superoxide formation in human aortic smooth muscle cell (2000) (0)
Antihypertensive effect of intravenously and orally administered bunitrolol (Kö 1366). (1979) (0)
[Action mechanism of angiotensin]. (1972) (0)
[Development of combined drugs (ARB and diuretics)]. (2004) (0)
-0986-ELECTROPHYSIOLOGIC CHARACTERISTICS ATINITIATION OF VENTRICULAR TACHYCARDIA AND VENTRICULAR FIBRILLATION IN AN INFARCT CANINE MODEL : ROLE OF CONDUCTION DELAY IN THE SITE OF ORIGIN : THE 54th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY (1990) (0)
Effects of β-adrenergic Stimulants (Denopamine, Terbutaline) on Serum Lipoprotein Metabolism in Healthy Men: ―ヒトにおける検討― (1990) (0)
EXERCISE THERAPY IN ELDERLY HYPERTENSIVE PATIENT (1998) (0)
[Effects of exogenous proteinase (pronase) on experimental arteriosclerosis and blood pressure]. (1966) (0)
Risk factors for coronary events and cerebral infarction in Japanese men with hypercholesterolemia: The Kyushu Lipid Intervention Study (KLIS) (2000) (0)
[Organ protection by antihypertensive measures]. (2004) (0)
Malignancy and HLA-DRw13 in patients on maintenance hemodialysis. (1987) (0)
[Plasmapheresis with membrane type plasma separator]. (1991) (0)
THE OPTIMAL BLOOD PRESSURE REDUCTION. DISUCSSION (1996) (0)
[Indication of antihypertensive drugs]. (1992) (0)
The Effect of the Chinese Herbal Drug Dai-saiko-to on Blood Pressure, Serum Lipids, Lipoproteins and Apolipoproteins in Essential Hypertension (1992) (0)
Characterization of renin-like activity in human plasma protein IV-4 fraction. (1975) (0)
TRYPTENSIN, A PRESSOR SUBSTANCE GENERATED BY TRYPSIN : SYMPOSIUM III : Diagnosis and Treatment (1977) (0)
[Renin angiotensin system as a regulator of blood pressure--pharmacological actions and its mechanisms]. (1992) (0)
Hypertension : progress in diagnosis and treatment. Treatment. General treatment of hypertension. (1990) (0)
Clinical efficacy and tolerability of candesartan cilexetil. Candesartan Study Groups in Japan. (1999) (0)
[Pathophysiology of the renin-angiotensin system]. (1999) (0)
Effect of trapidil on hypo-high-density lipoproteinemia in male schizophrenics (1986) (0)
An outbreak of penicillin-resistantStreptococcus pneumoniae infections on an internal medicine ward (1996) (0)
A rapid and practical determination of aldosterone in urine by double isotope method. (1971) (0)
Contents Vol. 94, 2000 (2001) (0)
The Authors Reply: (1993) (0)
[1984 revised guideline reported by the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure]. (1985) (0)
APPLICATION OF ANGIOTENSIN II IN FUNCTIONAL PHONOCARDIOGRAPHY (1969) (0)
Summary of 1993 WHO/ISH guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Guidelines Sub-Committee of WHO/ISH Mild Hypertension Liaison Committee. (1993) (0)
[Introduction: Seeing the forest as well as the tree]. (2006) (0)
OXIDATION OF TRIPEPTIDES CONTAINING HYDROXYAMINO ACID RESIDUE BY PERIODIC ACID (1958) (0)
Evaluation of hemodynamic effects of nitroglycerin on the utility of transesophageal echocardiography for diagnosis of coronary artery stenosis (1996) (0)
On the Utilization of Antihypertensive and Antibacterial Agents (2002) (0)
Physical Activity and Serum Lipids and Lipoproteins in Healthy Men (1986) (0)
Effects of a new calcium channel blocker, TA 3090, on serum lipoprotein levels in mild to moderate essential hypertension. (1990) (0)
2C-10 Effects of Aerobic Exercise on Serum Lipids and Lipoprotein Concentrations in Pre and Post Menopausal State : A Longitudinal Study (1999) (0)
Kikuo Arakawa and Hidenori Urata II Formation in Atherosclerosis Hypothesis Regarding the Pathophysiological Role of Alternative Pathways of Angiotensin (2000) (0)
[Measurement of renin and angiotensin in the blood and renal renin]. (1967) (0)
[Significance of determination of renin-angiotensin system in hypertension]. (1969) (0)
[Diagnostic methods for hypertension]. (1968) (0)
Effects of short- and long-term administration of nifedipine on serum lipoprotein metabolism in patients with mild hypertension (1990) (0)
Bovine Lipoprotein Lipase and Fibrinolysis (1987) (0)
Subject Index Vol. 94, 2000 (2001) (0)
Effects of troglitazone on serum lipids, lipoproteins, and hyperinsulinemia in Watanabe heritable hyperlipidemic rabbits (1997) (0)
[Physiology of circulation and the kallikrein-kinin system]. (1978) (0)
STUDIES ON GENERATION OF VASO-ACTIVE SUBSTANCES BY PLASMIN AND THROMBIN (1982) (0)
1.P.214 The long-term effect of LDL apheresis in a patient with heterozygous familial hypercholesterolemia (1997) (0)
Effect of Major Tranquilizers on the Concentration of Serum Lipids and Apolipoproteins: ―フェノチアジン, ブチロフェノン系薬剤について― (1985) (0)
[Exercise therapy of atherosclerosis]. (1993) (0)
The Effects of β-Adrenergic Stimulants (Denopamine, Terbutaline) on the Serum Lipid Levels in the Rat (1990) (0)
[Synthetic anti-angiotensin substances]. (1973) (0)
12) EXERCISE R WAVE AMPLITUDE AND ST-T CHANGES IN PATIENTS WITH CARDIOMYOPATHY (1982) (0)
Effect of Regular Aerobic Training on the Body Weight, Serum Lipids and HDL Cholesterol in Obese Children: ―血清脂質およびHDL-コレステロールの変動― (1986) (0)
[Interstitial nephritis caused by non-steroidal anti-inflammatory agents--report of 2 cases]. (1995) (0)
[Non pharmacological therapy in hypertensive patients--effect of physical exercise on hypertension]. (1997) (0)
1.P.389 Interaction effects of β1-selective β-blocker and Ca2+ channel blocker on serum lipoproteins in hypertensives (1997) (0)
ACE Inhibitors at the Kidney: Merck Sharp & Dohme Satellite Symposium, Kyoto, May 1988 (1990) (0)
-0769-EFFECTS OF THE CONVERTING ENZYME INHIBITOR ON REGIONAL CARDIAC FUNCTION IN PATIENTS WITH ONE VESSEL DISEASE (1990) (0)
[Hypertension and cancers]. (1995) (0)
3MP03 What is most important in treating hypertension (2003) (0)
[Angiotensin and its related substances]. (1967) (0)
Effect of Ketanserin on Lipoproteins in Patients with Essential Hypertension (2012) (0)
[Prescription of exercise for hypertension]. (2000) (0)
[Kidney diseases and abnormal lipoprotein metabolism]. (1983) (0)
RELATION BETWEEN THE RATIO OF CONDUCTION DELAY TO REFRACTORY PERIOD AND SUSCEPTIBILITY TO ATRIAL FIBTILLATION (1993) (0)
[Development and trends in antihypertensive drugs--introduction]. (2000) (0)
A case report: chronic fatigue syndrome with low CD4/CD8. (1993) (0)
Symposium(1) Kidney and Hypertension-With Special Reference to the Role of Renin Angiotensin System- Chemistry of Renin and Angiotensin (1965) (0)
[Significance of renin-angiotensin system in the development of hypertension--author's comments and viewpoint]. (1971) (0)
CHARACTERIZATION OF HUMAN APOLIPOPROTEIN A-I VARIANTS (1993) (0)
Role of endogenous ouabain-like substance during graded exercise in hypertensive individuals. (1996) (0)
-269-PATHOLOGICAL SUBSTRATUM FOR MYOCARDIAL FATTY INFILTRATION AND SUSTAINED VENTRICULAR TACHYCARDIA (1986) (0)
Increased chymase immunoreactive cells and T lymphocytes in the subepicardium of the infarcted myocardium in human (1999) (0)
PROTECTIVE EFFECT OF LOSARTAN ON REPERFUSION ARRHYTHMIAS IN THE DOG (1993) (0)
Author Index, Supple 1, Vol. 55, 1990 (1990) (0)
Body mass index as an independent indicator of blood pressure in normotensive Japanese. (1990) (0)
Effect of Exercise Associated on Hypertension Complications (2006) (0)
Effects of arotinolol on serum lipid and apolipoprotein levels in patients with mild essential hypertension. (1989) (0)
Administration of slow-release nifedipine does not affect lactate threshold, hormone release during exercise, and quality of life in normal subjects (1992) (0)
Effects of Short- and Long-Term Nifedipine on Serum Lipoprotein Patients with Mild Hypertension Administration of Metabolism in (1990) (0)
Leukocyte and band-form neutrophil counts are correlated to coronary atherosclerosis (1994) (0)
Effects of Aerobic Exercise on Lipoprotein and Apolipoprotein Levels in Male Patients with Coronary Artery Disease and Normal Control Men (1984) (0)
Lifestyle modification for treating hypertension: The Japanese point of view (1997) (0)
Apolipoprotein(a) phenotypes in patients with hypertension and a (1994) (0)
Subject Index, Supple 1, Vol. 55, 1990 (1990) (0)
[Biochemistry of the renin substrate]. (1982) (0)
The Effect of Cholestyramine in Hyperlipidemic Patients under Long-Term Therapy (1983) (0)
L002: Influence of angiotensin II type 1 receptor A/C1166 polymorphism on hypertension in patients with and without coronary atherosclerosis (1998) (0)
An Improved Measurement of Plasma Renin Level (1967) (0)
[Current topics on hypertension. At the conclusion of the 1998 meeting of the WHO/ISH Guideline Committee on the management of mild hypertension]. (1999) (0)
Title Prevention of MRSA spread in the neurosurgical field (2017) (0)
A procedure for improving the non-pharmacological management of the life style of hypertensive patients, computerised approach, the heart smart program (1995) (0)
ANTIHYPERTENSIVE ACTION OF PHYSICAL EXERCISE (1991) (0)
Relationship between hemoglobin A1c (HbA1c) levels and severity of thoracic aortic atherosclerosis (1994) (0)
Comparative Double-Blind Study of Ketanserin versus Propranolol in the Treatment of Essential Hypertension (2012) (0)
Report of a case of type A Wolff-Parkinson-White syndrome complicated with acute myocardial infarction and transient complete atrioventricular block (1984) (0)
Left atrial thrombus formation in patients with nonvalvular paroxysmal atrial fibrillation (2002) (0)
2.P.157 Apolipoprotein(a) phenotype and serum Lp(a) levels in patients with angina pectoris and myocardial infarction (1997) (0)
Multiple myeloma and sick sinus syndrome. (1985) (0)
[Role of hormone in blood pressure control]. (1970) (0)
Apolipoproteins of Human High Density Lipoproteins Activate Fibrinolysis (1986) (0)
COMMENTS TO DR. NAKASHIMA'S PAPER (1989) (0)
[General considerations in the treatment of hypertension]. (1990) (0)
[Syncope in atrial septal defect]. (1971) (0)
Effects of Monatepil, a Novel Calcium Antagonist with α1-Adrenergic Blocking Activity, on the Low-Density Lipoprotein Receptor in Human Skin Fibroblasts (1997) (0)
Serum Apolipoprotein and Lipid Levels in Coronary Heart Disease (1980) (0)
Method for preparing coating films (1968) (0)
Lack of effect of chlorpromazine and haloperidol on serum lipid levels and on atherogenesis in cholesterol fed rabbits. (1989) (0)
Long-term follow-up by coronary angiography in a patient with heterozygous familial hypercholesterolemia: a case report. (1997) (0)
HLA and cardiovascular disease. (1978) (0)
[Low renin hypertension]. (1978) (0)
How Does Exercise Lower Blood Pressure (1999) (0)
KININ FORMATION BY TONlWIkeda and Arakawa (2005) (0)
83. Influences of Low Salt Diet and Exercise on Plasma Renin Activity (1969) (0)
1.P.262 Characterization of apolipoprotein E3-Nanakuma (Ala214 → Val): An new apolipoprotein E3 variant detected by single strand conformation polymorphism (1997) (0)
THE EFFECTS OF LONG-TERM LOW INTENSITY AEROBIC TRAINING ON BLOOD PRESSURE IN HYPERTENSIVE ELDERLY PATIENTS 965 (1996) (0)
-0136-RELATIONSHIP OF ALCOHOL CONSUMPTION TO BLOOD PRESSURE AND SERUM LIPIDS (1990) (0)
The Influence of BKU (Urapidil Retard Capsules) on Diurnal Variations of Blood Pressure in Patients with Essential Hypertension (1986) (0)
Can improvement of insulin resistance by CS-045 protect against atherosclerosis? (1994) (0)
The authors reply. (2013) (0)
Physical Fitness and Body Fat Distribution: Relation to Risk Factors for Metabolic Diseases in Obese Women (1999) (0)
[Relation between nutrition of patients and methicillin-resistant Staphylococcus aureus (MRSA)]. (1996) (0)
Thoracic aortic atherosclerosis and hypoalphalipoproteinemia as an indicator for coronary heart disease (1999) (0)
[A case of idiopathic hyperaldosteronism diagnosed by adrenal imaging]. (1993) (0)
[Clinical studies of fluconazole in patients with deep-seated fungal infection in intravenous hyperalimentation (IVH)]. (1996) (0)
Characterization of a new human A-I Yame by direct sequencing of chain react ion-am plif ied DNA apolipoprotein polymerase (1991) (0)
[Takayasu's disease--clinical studies of 26 cases and experimental studies]. (1970) (0)
9) EXERCISE INDUCED VENTRICULAR PREMATURE BEATS IN VARIOUS HEART DISEASES USING THREE SPACIAL LEADS ECG : THE VIth CONFERENCE ON VECTORCARDIOGRAPHY (1981) (0)
OJ-249 Long-term Efficacy of Nifedipine Retard and ACE Inhibitors in Diabetic Patients with Hypertension and Coronary Artery Disease : JMIC-B Subgroup analysis(Hypertension, Clinical 5 (H) : OJ29)(Oral Presentation (Japanese)) (2004) (0)
Effect of Aerobic Exercise on Lipid and Apolipoprotein Levels in Patients with Essential Hypertension (1985) (0)
[Brief review: molecular biology of vasoactive substance and signal transduction]. (2000) (0)
[Clinical effects of labetalol in 21 patients with phaeochromocytoma (author's transl)]. (1981) (0)
[Clinical study of 143 patients treated at the kidney center in the Fukuoka University Hospital]. (1983) (0)
P548 THE RISK OF LEFT ATRIAL THROMBOSIS IN PATIENTS WITH CHRONIC ATRIAL FIBRILLATION AND PAROXYSMAL ATRIAL FIBRILLATION (1996) (0)
A case of pseudoxanthoma elasticum associated with sick sinus syndrome (1995) (0)
A SPATIAL ANALYSIS OF ST-T CHANGES OF THE FRANK LEAD EXERCISE ELECTROCARDIOGRAM USING THE DIFFERENCE VECTOR : THE III CONFERENCE ON VECTORCARDIOGRAPHY (1978) (0)
ASSOCIATION OF HLA TO RHEUMATIC HEART VALVULAR DISEASE : Ist Auditorium (1977) (0)
Effects of Mild Exercise Therapy on Serum High Density Lipoprotein Subfraction in Patients with Essential Hypertension (1986) (0)
-P286- CLINICOPATHOLOGICAL STUDIES OF PATHOLOGICALLY DMP-LIKE DILATED CARDIOMYOPATHY (1987) (0)
[Abnormal regulation of blood pressure--hemodynamic study]. (1984) (0)
[Salt hypertension in chimpanzees]. (2006) (0)
Effect of Nifedipine on Serum Lipoprotein Metabolism in Patients with Essential Hypertension (1989) (0)
[A case report: cryptococcal meningitis and fluconazole therapy]. (1994) (0)
Association of HLA-DRw13 with in Japanese patients with malignancy and end-stage renal disease. (1990) (0)
A case of nephrotic syndrome with urinary excretion of lipoproteins. (1984) (0)
A case of hypopituitarism and type V hyperlipidemia. (1989) (0)
Association of HLA-DRw13 with renal cell carcinoma developed in japanese patient with end-stage renal disease (1991) (0)
Clinical Studies Pathological Extent of Interventricular Septal Infarction in Patients with Acute Anteroseptal Myocardial Infarction with and without Right Bundle Branch (2008) (0)
[Renal hypertension]. (1971) (0)
Cardiac Rupture in a Patient with Old Myocardial Infarction: Rupture of Established Transmural Fibrosis (1994) (0)
[Maintenance and reconstruction of angioaccess for hemodialysis]. (1991) (0)
Confirmation of mutation for apolipoprotein E5 (Glu3 → Lys) by PCR-mediated site-directed mutagenesis and for E7 (Glu244,245 → Lys244,245) by amplification refractory mutation system (ARMS) (1994) (0)
Angiotensin II Receptor Antagonists: From Science to Clinical Practice Takeda Satellite Symposium Opening Remarks – Professor Kikuo Arakawa (1999) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Kikuo Arakawa?

Kikuo Arakawa is affiliated with the following schools:

Fukuoka University